Advertisement

AIDS and Behavior

, Volume 23, Issue 11, pp 2980–2991 | Cite as

Correlates of Durable Viral Suppression (DVS) Among Criminal Justice-involved (CJI) Black Men Living with HIV in Louisiana

  • Russell BrewerEmail author
  • Rodal Issema
  • Mary Moore
  • Sarah Chrestman
  • Snigdha Mukherjee
  • Michelle Odlum
  • John A. Schneider
Original Paper
  • 94 Downloads

Abstract

Durable viral suppression (DVS) is needed to reduce HIV transmission risk and prevent new HIV infections. We examined changes in viral suppression and correlates of DVS among 97 criminal justice-involved (CJI) Black men living with HIV in Louisiana enrolled in a linkage, re-engagement, and retention in care intervention. Most participants (75%) were Black men who have sex with men. Forty-four percent (44%) were virally suppressed at baseline and only 20% had achieved DVS over a 12-month period. Multinomial logistic regression analyses showed that compared with DVS participants, those with no viral suppression (NVS) and some viral suppression (SVS) were more likely to have lived with HIV for a longer period of time and were less likely to be adherent at baseline. Medication adherence was critical for DVS among this sample of CJI Black men living with HIV who represent a high priority population for HIV care and treatment interventions.

Keywords

Durable viral suppression Black men who have sex with men (BMSM) Criminal justice-involved HIV South 

Notes

Acknowledgments

We would like to thank our study participants, intervention sites, and collaborators.

Author’s Contribution

All authors contributed to concept development. RB generated the manuscript outline and contributed to the initial and subsequent versions. MM, RI, and MO contributed to data cleaning, methods, analyses, and the results section. SC, SM, and JAS contributed to the introduction, results, and discussion section. In addition, RB served as PI for the study with SC and SM as Co-Investigators.

Funding

This project was supported by a grant from AIDS United and the Corporation for National and Community Service (CNCS) with match funding provided by MAC AIDS Fund, Gilead Sciences, Inc., the Baton Rouge Area Foundation, and the Huey and Angelina Wilson Foundation. R. Brewer’s time was also supported by a grant from NIMH (R25MH067127) for the Visiting Professor Program at the University of California, San Francisco; The Centers for Disease Control and Prevention’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (5U01PS005122-03); and NIDA (3P30DA027828-08S1).

Compliance with Ethical Standards

Conflict of interest

Dr. Russell Brewer currently serves as advisory to Gilead’s Implementation Science Group and ViiV Healthcare’s Accelerate Initiative.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional Review Board approval was obtained for the study.

Informed Consent

Informed consent was obtained from all study participants.

References

  1. 1.
    White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States: updated to 2020. Washington: the White House: July 2015. https://www.whitehouse.gov/sites/whitehouse.gov/files/images/nhas-2016-progress-report.pdf. Accessed 14 June 2018.
  2. 2.
    Harawa N, Brewer R, Buckman V, et al. HIV, sexually transmitted infection and substance use continuum of care interventions among criminal justice involved Black men who have sex with men: a systematic review. Am J Public Health. 2018;108(S4):e1–9.  https://doi.org/10.2105/AJPH.2018.304698.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Brewer RA, Chrestman S, Mukherjee S, et al. Exploring the correlates of linkage to HIV medical care among persons living with HIV (PLWH) in the Deep South: lessons learned from the Louisiana Positive Charge Initiative. AIDS Behav. 2018.  https://doi.org/10.1007/s10461-018-2113-6.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Chen NE, Meyer JP, Avery AK, et al. Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav. 2013;17(8):2564–666.CrossRefGoogle Scholar
  5. 5.
    Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.CrossRefGoogle Scholar
  6. 6.
    Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38:1754–60.CrossRefGoogle Scholar
  7. 7.
    Baillargeon J, Giordano TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison. J Am Med Assoc. 2009;301(8):848–57.  https://doi.org/10.1001/jama.2009.202.CrossRefGoogle Scholar
  8. 8.
    Meyer JP, Cepeda J, Wu J, et al. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med. 2014;174(5):721–9.CrossRefGoogle Scholar
  9. 9.
    Dennis AC, Barrington C, Hino S, Gould M, Wohl D, Golin CE. “You’re in a world of chaos”: experiences accessing HIV care and adhering to medications after incarceration. J Assoc Nurses AIDS Care. 2015;26(5):542–55.CrossRefGoogle Scholar
  10. 10.
    Zelenev A, Marcus R, Kopelev A, et al. Patterns of homelessness and implications for HIV health after release from jail. AIDS Behav. 2013;17(Suppl 2):S181–94.CrossRefGoogle Scholar
  11. 11.
    Rozanova J, Brown SE, Bhushan A, Marcus R, Altice FL. Effect of social relationships on antiretroviral medication adherence for people living with HIV and substance use disorders and transitioning from prison. Health Justice. 2015;18(3):18.CrossRefGoogle Scholar
  12. 12.
    Kemnitz R, Kuehl TC, Hochstatter KR, et al. Manifestations of HIV stigma and their impact on retention in care for people transitioning from prisons to communities. Health Justice. 2017.  https://doi.org/10.1186/s40352-017-0054-1.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Vagenas P, Zelenev A, Altice FL, et al. HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study. AIDS Care. 2016;28(1):22–31.CrossRefGoogle Scholar
  14. 14.
    Schneider JA, Kozloski M, Michaels S, et al. Criminal justice involvement history is associated with better HIV care continuum metrics among a population-based sample of young black MSM. AIDS. 2017;31:159–65.CrossRefGoogle Scholar
  15. 15.
    Human Rights Watch. Paying the price. Failure to deliver HIV services in Louisiana Parish Jails. 2016. https://www.hrw.org/report/2016/03/29/paying-price/failure-deliver-hiv-services-louisiana-parish-jails. Accessed 11 March 2017.
  16. 16.
    State of Louisiana Department of Health, Office of Public Health. 2016 STD/HIV Program Report. http://www.ldh.la.gov/assets/oph/HIVSTD/std/STDAnnualReports/2016_STDHIV_SurveillanceReport_Final.pdf. Accessed 14 June 2018.
  17. 17.
  18. 18.
    ACE TA Center. Connecting recently incarcerated people living with HIV to health coverage and care. https://careacttarget.org/sites/default/files/supporting-files/ACE_Connecting_Recently_Incarcerated_PLWH_Health_Coverage_June2016.pdf. Accessed 14 June 2018.
  19. 19.
    Brewer RA, Magnus M, Kuo I, et al. Exploring the relationship between incarceration and HIV among black men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2014;65(2):218–25.CrossRefGoogle Scholar
  20. 20.
    Brewer RA, Magnus M, Kuo I, et al. The high prevalence of incarceration history among Black men who have sex with men in the United States: associations and implications. Am J Public Health. 2014;104(3):448–54.CrossRefGoogle Scholar
  21. 21.
    Meyer IH, Flores AR, Stemple L, et al. Incarceration rates and traits of sexual minorities in the United States: national inmate survey, 2011–2012. Am J Public Health. 2017;107(2):267–73.CrossRefGoogle Scholar
  22. 22.
    Centers for Disease Control and Prevention. HIV in the United States: At a glance. 2017. https://www.cdc.gov/hiv/pdf/statistics/overview/cdc-hiv-us-ataglance.pdf. Accessed 14 June 2018.
  23. 23.
    Crepaz N, Tang T, Marks G, Mugavero MJ, Espinoza L, Hall HI. Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012–2013. Clin Infect Dis. 2016;63:976–83.CrossRefGoogle Scholar
  24. 24.
    Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care- United States, 2014. MMWR. 2018;67(4):113–8.PubMedGoogle Scholar
  25. 25.
    Crawford TN, Thornton A. Retention in continuous care and sustained viral suppression: examining the association among individuals living with HIV. J Int Assoc Providers AIDS Care. 2017;16(1):42–7.CrossRefGoogle Scholar
  26. 26.
    Jefferson KA, Kersanske LS, Wolfe ME, et al. Place-based predictors of HIV viral suppression and durable suppression among men who have sex with men in New York city. AIDS Behav. 2017;21:2987–99.CrossRefGoogle Scholar
  27. 27.
    Wood SM, Lowenthal E, Lee S, Ratcliffe SJ, Dowshen N. Longitudinal viral suppression among a cohort of adolescents and young adults with behaviorally acquired human immunodeficiency virus. AIDs Patient Care STDs. 2017;31:377–83.CrossRefGoogle Scholar
  28. 28.
    Spaulding AC, Booker CA, Freeman SH, et al. Jails, HIV testing, and linkage to care services: an overview of the EnhanceLink initiative. AIDS Behav. 2013;17:S100–7.CrossRefGoogle Scholar
  29. 29.
    Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19:522–31.CrossRefGoogle Scholar
  30. 30.
    Kim JJ, Maulsby C, Kinsky S, et al. The development and implementation of the national evaluation strategy of access to care, a multi-site linkage to care initiative in the United States. AIDS Educ Prev. 2014;26:429–44.CrossRefGoogle Scholar
  31. 31.
    Jain KM, Holtgrave DR, Maulsby C, et al. Improving access to HIV care: lessons from 5 US sites. Baltimore: Johns Hopkins University Press; 2016.Google Scholar
  32. 32.
    Brewer RA, Chrestman S, Mukherjee S, et al. Exploring the correlates of linkage to HIV medical care among persons living with HIV (PLWH) in the Deep South: lessons learned from the Louisiana Positive Charge Initiative. AIDS Behav. 2018.  https://doi.org/10.1007/s10461-018-2113-6.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Maulsby C, Sacamano P, Jain KM, et al. Barriers and facilitators to the implementation of a national HIV linkage, re-engagement, and retention in care program. AIDS Educ Prev. 2017;29(5):443–56.CrossRefGoogle Scholar
  34. 34.
    Brantley AD, Page KM, Zack B, et al. Making the connection: using videoconferencing to increase linkage to care for incarcerated persons living with HIV post-release. AIDS Behav. 2018.  https://doi.org/10.1007/s10461-018-2115-4.CrossRefGoogle Scholar
  35. 35.
    Butler B, Murphy J. The impact of policies promoting health information technology on health care delivery in jails and local communities. Health Aff. 2014;33:487–92.CrossRefGoogle Scholar
  36. 36.
    Sowell RL, Lowenstein A, Moneyham L, et al. Resources, stigma, and patterns of disclosure in rural women with HIV infection. Public Health Nurs. 1997;14(5):302–12.CrossRefGoogle Scholar
  37. 37.
    Koblin BA, Mayer KH, Eshleman SH, et al. Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061. PLoS ONE. 2013;8(7):e70413.CrossRefGoogle Scholar
  38. 38.
    Huang FY, Chung H, Kroenke K, et al. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006;21(6):547–52.CrossRefGoogle Scholar
  39. 39.
    Peters RH, Greenbaum PE, Steinberg ML, et al. Effectiveness of screening instruments in detecting substance use disorders among prisoners. J Subst Abuse Treat. 2000;18(4):349–58.CrossRefGoogle Scholar
  40. 40.
    Erlen JA, Cha E, Kim KH, et al. The HIV medication taking self-efficacy scale: psychometric evaluation. J Adv Nurs. 2010;66(11):2560–72.CrossRefGoogle Scholar
  41. 41.
    Southwest Louisiana AIDS Council (SLAC). HIV adherence treatment form. https://www.slac.org/. Accessed 14 June 2018.
  42. 42.
    StataCorp. Stata statistical software: release 14. College Station: StataCorp LP; 2015.Google Scholar
  43. 43.
    Beckwith C, Castonguay BU, Trezza C, et al. Gender difference in HIV care among criminal justice-involved persons: baseline data from the CARE + corrections study. PLoS ONE. 2017;12(1):e0169078.  https://doi.org/10.1371/journal.pone.0169078.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Schneider JA, Lancki N, Schumm P. At the intersection of criminal justice involvement and sexual orientation: dynamic networks and health among a population-based sample of young Black men who have sex with men. Social Networks. 2017;51:73–87.CrossRefGoogle Scholar
  45. 45.
    Chander G, Himelhoch S, Fleishman JA, et al. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care. 2009;21(5):655–63.CrossRefGoogle Scholar
  46. 46.
    Yehia BR, Stephens-Shield AJ, Momplaisir F, et al. Health outcomes of HIV-infected people with mental illness. AIDS Behav. 2015;19(8):1491–500.CrossRefGoogle Scholar
  47. 47.
    Chuah FLH, Haldane VE, Cervero-Liceras F, et al. Interventions and approaches to integrating HIV and mental health services: a systematic review. Health Policy Plan. 2017;32(Suppl 4):iv27–47.CrossRefGoogle Scholar
  48. 48.
    Brewer R, Daunis C, Ebaady S, et al. Implementation of a socio-structural demonstration project to improve HIV outcomes among young Black men in the Deep South. J Racial Ethn Health Disparities. 2019.  https://doi.org/10.1007/s40615-019-00576-x.CrossRefPubMedGoogle Scholar
  49. 49.
    Manne-Goehler J, Siedner MJ, Montana L, et al. Hypertension and diabetes control along the HIV care cascade in rural South Africa. JIAS. 2019;22(3):e25213.  https://doi.org/10.1002/jia2.25213.CrossRefGoogle Scholar
  50. 50.
    Claborn KR, Meier E, Miller MB, Leffingwell TR. A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychol Health Med. 2015;20(3):255–65.CrossRefGoogle Scholar
  51. 51.
    Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Ann Behav Med. 2010;40:184–90.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of MedicineUniversity of ChicagoChicagoUSA
  2. 2.Dillard UniversityNew OrleansUSA
  3. 3.Louisiana Public Health InstituteNew OrleansUSA
  4. 4.Educational Commission for Foreign Graduates (ECFG)PhiladelphiaUSA
  5. 5.Columbia UniversityNew YorkUSA
  6. 6.Chicago Center for HIV EliminationChicagoUSA

Personalised recommendations